KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $274,772,000 | +11.9% | 1,528,805 | -35.4% | 0.06% | +8.9% |
| Q2 2017 | $245,465,000 | +29.0% | 2,367,752 | -2.3% | 0.06% | +30.2% |
| Q1 2017 | $190,303,000 | +41.7% | 2,424,565 | -19.0% | 0.04% | +34.4% |
| Q4 2016 | $134,288,000 | -7.8% | 2,994,847 | +14.8% | 0.03% | -11.1% |
| Q3 2016 | $145,683,000 | -8.0% | 2,607,976 | -17.7% | 0.04% | -7.7% |
| Q2 2016 | $158,402,000 | +23.7% | 3,168,056 | +13.6% | 0.04% | +18.2% |
| Q1 2016 | $128,014,000 | -8.1% | 2,788,395 | +23.4% | 0.03% | -5.7% |
| Q4 2015 | $139,272,000 | +63.5% | 2,260,173 | +47.8% | 0.04% | +52.2% |
| Q3 2015 | $85,156,000 | -17.3% | 1,529,380 | -9.5% | 0.02% | -4.2% |
| Q2 2015 | $103,018,000 | +45.0% | 1,689,642 | +37.2% | 0.02% | +50.0% |
| Q1 2015 | $71,028,000 | +49.0% | 1,231,433 | +49.0% | 0.02% | +45.5% |
| Q4 2014 | $47,668,000 | +122.5% | 826,566 | +10.0% | 0.01% | +120.0% |
| Q3 2014 | $21,422,000 | – | 751,626 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|